![Hui Jun Wang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hui Jun Wang
Amministratore Delegato presso
OBI PHARMA, INC.
Profilo
Hui Jun Wang is currently Chief Executive Officer at OBI Pharma, Inc. and Chairman at Obigen Pharma, Inc. since 2023.
Formerly, served as Vice President & Global Head-Regulatory Science at Bristol-Myers Squibb (Taiwan) Ltd. Earned a doctorate from the University of Notre Dame.
Posizioni attive di Hui Jun Wang
| Società | Posizione | Inizio |
|---|---|---|
| OBIGEN PHARMA INC. | Presidente | 29/12/2023 |
| OBI PHARMA, INC. | Amministratore Delegato | - |
Precedenti posizioni note di Hui Jun Wang
| Società | Posizione | Fine |
|---|---|---|
Bristol-Myers Squibb (Taiwan) Ltd. | Corporate Officer/Principal | - |
Formazione di Hui Jun Wang
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
21
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb (Taiwan) Ltd. | |
OBI Pharma, Inc.
 OBI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures anti-infective and immunotherapy drugs | Health Technology |
Obigen Pharma, Inc.
 Obigen Pharma, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures botulinum toxin products | Health Technology |
